Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azimilide vs Sotalol in Atrial Fibrillation (A-COMET-II)
NCT00035451Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Feb 2001
- Primary completion
- Jun 2003
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of azimilide in Atrial fibrillation (AFib), sponsored by Forest Laboratories. Started Feb 2001; status: completed.
02
Drugs
azimilide
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00035451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035451.